-transparent.png){kind=logo}
There are many studies demonstrating by different experimental models that non-steroidal antiinflammatory drugs (NSAIDs), also known as cyclooxygenase-2 (COX-2) inhibitors, can modulate immune response such as lymphoid cells differentiation and proliferation. There are experimental data which show that activated B cells can express mRNA COX-2, release prostaglandins (PGs) and produce immunoglobulins in PGs dependent manner. In this study, using different COX-2 inhibitors and applying personalized immunization scheme, we confirmed that it is possible to modulate in vivo antibody response against T cell dependent antigens, substantiating the importance of PGE2 and E prostanoid receptor (EP-R) in antibody generation. Our results point out the fact that we must be more careful when we apply vaccines containing T-cell dependent antigens, such as tetanus or diphteric anatoxin, to the patients under an intense antiinflammatory treatment.
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
May 1980,
Immunology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
May 1992,
Immunology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
January 2005,
Medicina,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
January 2014,
Frontiers in immunology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
January 1998,
Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
December 1999,
BMJ (Clinical research ed.),
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
September 1991,
Immunobiology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
March 2005,
Molecular and cellular biology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
December 1994,
International immunology,
Andreea-Roxana Lupu, and
Lidia Cremer, and
Steliana Durbacă, and
Ana Călugaru, and
Aurora Herold, and
F Kerek, and
G Szegli, and
D L Radu
January 1983,
Immunological communications,
